Which safety statements apply to isotretinoin therapy?

Which safety statements apply to isotretinoin therapy?

• A. Enroll in a risk management plan and use two forms of birth control
• B. Enroll in a risk management plan only
• C. Use two forms of birth control only
• D. Enroll in a risk management plan and use two forms of birth control (redundant)

Answer: (D)

Isotretinoin is highly teratogenic, so safety hinges on two safeguards working together. First, enrollment in a risk management plan ensures the patient is properly informed, eligible, and monitored, with controlled dispensing and required testing and follow-up. Second, using two forms of birth control provides a robust barrier against pregnancy during treatment, which is essential given the drug’s severe potential to cause birth defects. Because both safeguards are necessary to prevent fetal exposure, the most complete safety statement is to do both: enroll in the risk management plan and use two forms of birth control.

Isotretinoin is highly teratogenic, so safety hinges on two safeguards working together. First, enrollment in a risk management plan ensures the patient is properly informed, eligible, and monitored, with controlled dispensing and required testing and follow-up. Second, using two forms of birth control provides a robust barrier against pregnancy during treatment, which is essential given the drug’s severe potential to cause birth defects. Because both safeguards are necessary to prevent fetal exposure, the most complete safety statement is to do both: enroll in the risk management plan and use two forms of birth control.